Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity-Reference-Cited by-同舟云学术

Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity

Published:2005-06-30 Issue:21 Volume:12 Page:1544-1550
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Marano R J,Toth I,Wimmer N,Brankov M,Rakoczy P E

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3302579.pdf

Reference27 articles.

1. Ohno-Matsui K et al. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. J Cell Physiol 2001; 189: 323–333.

2. Aiello LP et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480–1487.

3. Boulton M, Foreman D, Williams G, McLeod D . VEGF localisation in diabetic retinopathy. Br J Ophthalmol 1998; 82: 561–568.

4. Siemeister G, Martiny-Baron G, Marme D . The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities. Cancer Metast Rev 1998; 17: 241–248.

5. Bainbridge JW et al. Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. Gene Therapy 2002; 9: 320–326.

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-angiogenic biomolecules in neovascular age-related macular degeneration; therapeutics and drug delivery systems;International Journal of Pharmaceutics;2024-06

2. Age-associated macular degeneration: Epidemiologic features, complications, and potential therapeutic approaches;Targeting Angiogenesis, Inflammation, and Oxidative Stress in Chronic Diseases;2024

3. An Update on Strategies to Deliver Protein and Peptide Drugs to the Eye;ACS Omega;2023-09-22

4. Next-Generation Nanomedicine Approaches for the Management of Retinal Diseases;Pharmaceutics;2023-07-22

5. Precision Medicines for Retinal Lipid Metabolism-Related Pathologies;Journal of Personalized Medicine;2023-04-05